MANITOBA CHILD HEALTH ATLAS 2004
kids photo (120x80 px)
 
GENETICS

Since May 1999, the Manitoba Maternal Serum Screening Programme has made "Triple Test" screening available to all pregnant women in Manitoba (prior to this time the alpha-fetoprotein screening test was available to all pregnant women in Manitoba). The Triple Test is a blood test that screens for chromosomal abnormalities and birth defects. This blood test is voluntary, and the graphs in this section show the rate of women giving birth who had the screen performed during their pregnancies. Different rates of uptake are likely influenced by the patients' perceptions of risks and benefits, their socioeconomic status, and their attitudes toward abortion. Further, a patient's decision to have the genetic test may be affected by the physician's attitude and the information provided during early prenatal visits.
[excel] [pdf] Rate of Women Giving Birth who had Triple Test Performed During Pregnancy, by Region, 2000/01 - 01/02
[excel] [pdf] Rate of Women Giving Birth who had Triple Test Performed During Pregnancy, by SES Group, 2000/01 - 2001/02
[excel] [pdf] Rate of Women Giving Birth who had Triple Test Performed During Pregnancy, by Mothers' Age at Delivery, 2000/01 - 2001/02

 

Key Findings:
Education

Education summary report

Winnipeg
right arrow Report
(20-page pdf)
right arrow Figures from Report *
right arrow Summary

Non-Winnipeg
right arrow Rural and Northern Health Care Meeting Presentation *
 
* PowerPoint file can be downloaded for notes.

© 2004 University of Manitoba


Last modified on Tuesday, 05-Jul-2005 22:37:00 CDT